Joseph Schwartz Leerink Partners Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
17
Avg Return
Past Year
Past Year
19%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
50%
Neutral
50%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Market Perform
Downgraded
| $1 |
176%
upside
| 1 | – |
–
| 24 Feb ‘26 2 months ago |
|
|
|
Outperform
Maintained
| $70 |
190%
upside
| 1 | +11% |
0
%
| 30 Dec ‘25 3 months ago |
|
|
|
Market Perform
Downgraded
| $14.50 |
0%
upside
| 1 | – |
–
| 29 Dec ‘25 3 months ago |
|
|
|
Market Perform
Downgraded
| $1 |
871%
upside
| 1 | – |
–
| 3 Dec ‘25 4 months ago |
|
|
|
Outperform
Upgraded
| $160 |
194%
upside
| 2 | -32% |
0
%
| 3 Dec ‘25 4 months ago |
|
|
|
Outperform
Upgraded
| $14 |
12%
upside
| 1 | +22% |
0
%
| 3 Dec ‘25 4 months ago |
|
|
|
Market Perform
Downgraded
| $2 |
35%
upside
| 1 | – |
–
| 3 Dec ‘25 4 months ago |
|
|
|
Market Perform
Downgraded
| $60 |
13%
upside
| 1 | – |
–
| 3 Dec ‘25 4 months ago |
|
|
|
Market Perform
Downgraded
| $16 |
0%
upside
| 1 | – |
–
| 3 Dec ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $60 |
233%
upside
| 2 | +31% |
0
%
| 10 Nov ‘25 5 months ago |
|
|
|
Outperform
Initiated
| $115 |
116%
upside
| 1 | -25% |
0
%
| 10 Nov ‘25 5 months ago |
|
|
|
Market Perform
Downgraded
| $72 |
1%
downside
| 1 | – |
–
| 27 Oct ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $88 |
130%
upside
| 1 | -17% |
0
%
| 29 Sep ‘25 6 months ago |
|
|
|
Market Perform
Maintained
| $15 |
26%
downside
| 1 | – |
–
| 9 Sep ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $20 |
2%
upside
| 1 | +41% |
0
%
| 7 Jul ‘25 9 months ago |
|
|
|
Outperform
Maintained
| $115 |
15%
downside
| 1 | +103% |
0
%
| 10 Jun ‘25 10 months ago |
|
|
|
Outperform
Upgraded
| $12 |
53%
upside
| 1 | +24% |
0
%
| 23 May ‘25 11 months ago |
|
|
|
Market Perform
Downgraded
| $7 |
14%
downside
| 1 | – |
–
| 30 Apr ‘25 1 year ago |
|